Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.588 USD | +3.54% | +16.20% | +7.45% |
05-09 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.45% | 118M | |
+7.72% | 111B | |
+11.13% | 106B | |
-12.18% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.73% | 16.81B | |
+38.60% | 12.54B | |
-24.51% | 8.09B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Wells Fargo Adjusts Price Target on Sangamo Therapeutics to $20 From $22, Maintains Overweight Rating